Publications

5674 Results

Chlorozotocin: Results in colorectal carcinoma treated with high and low doses. A Southwest Oncology Group study.

Authors
CD Haas;JD McCracken;CB Vaughn;RL Stephens;RM Bukowski;HJ Eyre
Journal / Conference
Invest New Drugs 2:401-404
Year
1984
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-7833

Phase II trial of amsacrine in pancreatic carcinoma: A Southwest Oncology Group study.

Authors
M Inamasu;N Oishi;T Chen;S Legha;J McCracken;S Balcerzak;R Stephens;R O'Bryan;SE Rivkin;JJ Costanzi;RB Natale;LH Baker;CA Coltman Jr
Journal / Conference
Cancer Treat Rep 68:1411-1412
Year
1984
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-7931

SWOG large bowel postoperative program. An update.

Authors
FJ Panettiere;TT Chen
Journal / Conference
4th International Conference on the Adjuvant Therapy of Cancer (Tucson March 1984) 94
Year
1984
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-7510

Characteristics of long term survivors receiving chemotherapy for pancreatic adenocarcinoma in Southwest Oncology Group (SWOG) studies.

Authors
RM Bukowski
Journal / Conference
ASCO #C-583
Year
1984
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-7738, SWOG-8040

Hepatic artery infusion (HAI) with 5FUDR (F), Adriamycin (A) and Streptozotocin (ST) in unresectable hepatoma. A Southwest Oncology Group study.

Authors
R Shildt;L Baker;W Stuckey
Journal / Conference
ASCO #C-587
Year
1984
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-7969

Pre-operative adjuvant therapy for squamous cell cancer (SCC) of the esophagus: SWOG & RTOG clinical trials.

Authors
L Leichman;HG Seydel;Z Steiger
Journal / Conference
ASCO #C-575
Year
1984
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-8037

Bisantrene hydrochloride in gastric adenocarcinoma. A SWOG study.

Authors
FJ Panettiere
Journal / Conference
AACR #688
Year
1984
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-8120

Phase II trial of Aclacinomycin A in advanced colorectal cancer using two dosage schedules: A Southwest Oncology Group study.

Authors
FE Bull;LH Baker;JD Bonnet;DO Dixon
Journal / Conference
ASCO #C-581
Year
1984
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-8206

Adriamycin and cyclophosphamide versus hydroxyurea in advanced prostatic cancer. A randomized Southwest Oncology Group study.

Authors
RL Stephens;C Vaughn;M Lane;J Costanzi;R O'Bryan;SP Balcerzak;H Levin;J Frank;CA Coltman Jr
Journal / Conference
Cancer 53:406-410
Year
1984
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-7630

Dose-response and dose-survival advantage for high versus low-dose Cisplatin combined with Vinblastine and Bleomycin in disseminated testicular cancer. A Southwest Oncology Group study.

Authors
MK Samson;SE Rivkin;SE Jones;JJ Costanzi;AF LoBuglio;RL Stephens;EA Gehan;GD Cummings
Journal / Conference
Cancer 53:1029-1035
Year
1984
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-7817